E-cigarettes as a Harm Reduction Strategy - Trial NCT06277271
Access comprehensive clinical trial information for NCT06277271 through Pure Global AI's free database. This phase not specified trial is sponsored by Prisma Health-Upstate and is currently Recruiting. The study focuses on Smoking. Target enrollment is 30 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Prisma Health-Upstate
Timeline & Enrollment
N/A
Jun 20, 2023
Mar 20, 2024
Primary Outcome
Percentage of people who are eligible,Percentage of consented participants,Percentage of participants who report using the e-cigarette at least once a day,Percentage of participants with at least one puff of study e-cigarette,Percentage of daily diary completed
Summary
E-cigarettes have emerged as an effective strategy for replacing cigarettes among smokers
 from the general population, but there is a dearth of studies investigating their utility in
 replacing cigarettes among smokers with opioid use disorder (OUD). This study aims to
 evaluate the feasibility and acceptability of implementing a cigarette harm reduction
 intervention involving e-cigarettes in office-based buprenorphine clinics.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06277271
Non-Device Trial